Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA) decreased 0.34% to close at $49.11. TEVA traded 6.25 million shares for the day and its earning per share remained $3.25. Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical company that develops, produces and markets generic drugs covering all treatment categories. The Company has a pharmaceutical business, whose principal products are Copaxone for multiple sclerosis and Azilect for Parkinson�s disease, respiratory products and women�s health products. On January 29, 2009, the Company sold its Israeli animal health product line to Phibro Animal Health Corporation.
Amgen, Inc. (NASDAQ:AMGN) decreased 0.61% to close at $53.40. AMGN traded 4.07 million shares for the day and its earning per share remained $4.63. Amgen Inc. (Amgen) is an independent biotechnology medicines company. The Company discovers, develops, manufactures and markets medicines for grievous illnesses. It focuses on human therapeutics and concentrates on medicines based on advances in cellular and molecular biology. Its principal products include Aranesp (darbepoetin alfa) and EPOGEN (Epoetin alfa), erythropoietic-stimulating agents (ESAs) that stimulate the production of red blood cells; an inhibitor of tumor necrosis factor (TNF), a substance that plays a role in the body�s response to inflammatory diseases.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) increased 7.07% to close at $4.39. ARIA traded 2.61 million shares for the day and its earning per share remained $0.88. ARIAD Pharmaceuticals, Inc. (ARIAD) is a biopharmaceutical company focused on the discovery and development of drugs to provide therapeutic intervention in treating human diseases at the cellular level. The Company�s lead cancer product candidate, ridaforolimus, is an internally discovered, potent inhibitor of the protein mTOR. Its third product candidate, AP26113, is an investigational anaplastic lymphoma kinase (ALK), including non-small cell lung cancer, lymphoma and neuroblastoma.
No comments:
Post a Comment